Eli Lilly and Company (LLY.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 12:41PM CEST. Market open.
| Previous Close | 684.00 |
| Open | 675.10 |
| Bid | 0.00 x 30000 |
| Ask | 0.00 x 30000 |
| Day's Range | 673.20 - 678.90 |
| 52 Week Range | 341.00 - 737.00 |
| Volume | |
| Avg. Volume | 650 |
| Market Cap | 643.018B |
| Beta (5Y Monthly) | 0.37 |
| PE Ratio (TTM) | 125.22 |
| EPS (TTM) | 5.40 |
| Earnings Date | Apr 30, 2024 |
| Forward Dividend & Yield | 4.75 (0.69%) |
| Ex-Dividend Date | Feb 14, 2024 |
| 1y Target Est | N/A |
ZacksWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Zacks4 Large Drug Stocks to Hold on to Amid Industry Challenges
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
ZacksAnalysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.